Romanian health official denies oncological drug shortages despite patient reports of treatment delays

The president of Romania's National Health Insurance House (CNAS) claims there have been no oncological drug supply disruptions, directly contradicting reports from patients who state they were denied treatment due to shortages. The discrepancy highlights a potential failure in supply chain transparency or administrative reporting regarding critical cancer care.